TY - JOUR
T1 - Transcriptional and Neurochemical Signatures of Cerebral Blood Flow Alterations in Individuals With Schizophrenia or at Clinical High Risk for Psychosis
AU - Knight, Samuel R.
AU - Abbasova, Leyla
AU - Zeighami, Yashar
AU - Hansen, Justine Y.
AU - Martins, Daniel
AU - Zelaya, Fernando
AU - Dipasquale, Ottavia
AU - Liu, Thomas
AU - Shin, David
AU - Bossong, Matthijs
AU - Azis, Matilda
AU - Antoniades, Mathilde
AU - Howes, Oliver D.
AU - Bonoldi, Ilaria
AU - Egerton, Alice
AU - Allen, Paul
AU - O'Daly, Owen
AU - McGuire, Philip
AU - Modinos, Gemma
N1 - Publisher Copyright:
© 2025 Society of Biological Psychiatry
PY - 2025/7/15
Y1 - 2025/7/15
N2 - Background: The brain integrates multiple scales of description, from the level of cells and molecules to large-scale networks and behavior. Understanding relationships across these scales may be fundamental to advancing understanding of brain function in health and disease. Recent neuroimaging research has shown that functional brain alterations that are associated with schizophrenia spectrum disorders (SSDs) are already present in young adults at clinical high risk for psychosis (CHR-P), but the cellular and molecular determinants of these alterations remain unclear. Methods: Here, we used regional cerebral blood flow (rCBF) data from 425 individuals (122 with an SSD compared with 116 healthy control participants [HCs] and 129 individuals at CHR-P compared with 58 HCs) and applied a novel pipeline to integrate brainwide rCBF case-control maps with publicly available transcriptomic data (17,205 gene maps) and neurotransmitter atlases (19 maps) from 1074 healthy volunteers. Results: We identified significant correlations between astrocyte, oligodendrocyte, oligodendrocyte precursor cell, and vascular leptomeningeal cell gene modules for both SSD and CHR-P rCBF phenotypes. Additionally, endothelial cell genes were correlated in SSD, and microglia in CHR-P. Receptor distribution significantly predicted case-control rCBF differences, with dominance analysis highlighting dopamine (D1, D2, dopamine transporter), acetylcholine (VAChT, M1), gamma-aminobutyric acid A (GABAA), and glutamate (NMDA) receptors as key predictors for SSD (R2adjusted = 0.58, false discovery rate [FDR]–corrected p <.05) and CHR-P (R2adjusted = 0.6, pFDR <.05) rCBF phenotypes. These associations were primarily localized in subcortical regions and implicate cell types involved in stress response and inflammation, alongside specific neuroreceptor systems, in shared and distinct rCBF phenotypes in psychosis. Conclusions: Our findings underscore the value of integrating multiscale data as a promising hypothesis-generating approach toward decoding biological pathways involved in neuroimaging-based psychosis phenotypes, potentially guiding novel interventions.
AB - Background: The brain integrates multiple scales of description, from the level of cells and molecules to large-scale networks and behavior. Understanding relationships across these scales may be fundamental to advancing understanding of brain function in health and disease. Recent neuroimaging research has shown that functional brain alterations that are associated with schizophrenia spectrum disorders (SSDs) are already present in young adults at clinical high risk for psychosis (CHR-P), but the cellular and molecular determinants of these alterations remain unclear. Methods: Here, we used regional cerebral blood flow (rCBF) data from 425 individuals (122 with an SSD compared with 116 healthy control participants [HCs] and 129 individuals at CHR-P compared with 58 HCs) and applied a novel pipeline to integrate brainwide rCBF case-control maps with publicly available transcriptomic data (17,205 gene maps) and neurotransmitter atlases (19 maps) from 1074 healthy volunteers. Results: We identified significant correlations between astrocyte, oligodendrocyte, oligodendrocyte precursor cell, and vascular leptomeningeal cell gene modules for both SSD and CHR-P rCBF phenotypes. Additionally, endothelial cell genes were correlated in SSD, and microglia in CHR-P. Receptor distribution significantly predicted case-control rCBF differences, with dominance analysis highlighting dopamine (D1, D2, dopamine transporter), acetylcholine (VAChT, M1), gamma-aminobutyric acid A (GABAA), and glutamate (NMDA) receptors as key predictors for SSD (R2adjusted = 0.58, false discovery rate [FDR]–corrected p <.05) and CHR-P (R2adjusted = 0.6, pFDR <.05) rCBF phenotypes. These associations were primarily localized in subcortical regions and implicate cell types involved in stress response and inflammation, alongside specific neuroreceptor systems, in shared and distinct rCBF phenotypes in psychosis. Conclusions: Our findings underscore the value of integrating multiscale data as a promising hypothesis-generating approach toward decoding biological pathways involved in neuroimaging-based psychosis phenotypes, potentially guiding novel interventions.
KW - Arterial spin labeling
KW - Biomarkers
KW - Gene expression
KW - Mental health
KW - Neuroimaging
KW - Neurotransmitters
UR - https://www.scopus.com/pages/publications/105002781445
U2 - 10.1016/j.biopsych.2025.01.028
DO - 10.1016/j.biopsych.2025.01.028
M3 - Article
C2 - 39923816
AN - SCOPUS:105002781445
SN - 0006-3223
VL - 98
SP - 144
EP - 155
JO - Biological Psychiatry
JF - Biological Psychiatry
IS - 2
ER -